EQL Pharma Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Axel Schörling, was filed 27 May 2024.
EQL Pharma: what insiders have been doing
EQL Pharma is a listed company. Its insiders report their share dealings to Finansinspektionen. No insider at EQL Pharma has published a filing in the past twelve months. The most recent one dates from 27 May 2024.
Over the whole record (from 2018), the tally stands at 8 purchases and 3 sales.
Elsewhere in the same market, our signals recently picked up insider purchases at Dynavox Group AB and Rusta AB (publ). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
- 53,903 shares@ SEK 47.05100.0% of flowAktieISIN SE0005497732FI:csv-f205bf7de5ad065f8cd9Canonical exit: 22 Aug 2024 (T+90)
- 243,232 shares0TeckningsrättISIN SE0011844166FI:csv-eb4b77b871ba65e038a9
- 243,232 shares0TeckningsrättISIN SE0011844166FI:csv-92768fb52da43a2e9116Canonical exit: 5 Feb 2019 (T+90)
- 40,538 shares@ SEK 6.0049.9% of flowTeckningsrättISIN SE0011844174FI:csv-4c7d8eafc0b69b85e40b
- 4 shares@ SEK 0.450.0% of flowTeckningsrättISIN SE0011844166FI:csv-41e0ffdc2bb1d2fa8ed1
- 243,232 shares0TeckningsrättISIN SE0011844166FI:csv-c0f595c70d16cce1da4b
- 40,700 shares@ SEK 6.0050.1% of flowAktieISIN SE0011844174FI:csv-ae011f087e30c868b1f6
- 244,200 shares0TeckningsrättISIN SE0011844166FI:csv-3dbca055e29daaee630b
- 17,000 shares@ SEK 9.9010.1% of flowAktieISIN SE0005497732FI:csv-39625fef6d9e9ec79e27Canonical exit: 6 Feb 2019 (T+90)
- 3,231,865 shares@ SEK 0.4078.4% of flowTeckningsrättISIN SE0011844166FI:csv-d49de7e8ece44c241cffCanonical exit: 7 Feb 2019 (T+90)
- 316,800 shares@ SEK 0.6011.5% of flowTeckningsrättISIN SE0011844166FI:csv-e5afd4c3a0d037f24adaCanonical exit: 3 Feb 2019 (T+90)
- 19,800 shares@ SEK 0.60100.0% of flowTeckningsrättISIN SE0011844166FI:csv-9bd62320fcefaceb00e2
- 28,960 shares@ SEK 0.4142.8% of flowTeckningsrättISIN SE0011844166FI:csv-4089fe474dc49479f0b1Canonical exit: 4 Feb 2019 (T+90)
- 20,000 shares@ SEK 0.4230.3% of flowTeckningsrättISIN SE0011844166FI:csv-aa3c11616f7b0074d3abCanonical exit: 4 Feb 2019 (T+90)
- 16,240 shares@ SEK 0.4627.0% of flowTeckningsrättISIN SE0011844166FI:csv-597ed154dc44e5756304Canonical exit: 3 Feb 2019 (T+90)
15 of 15 declarations
About EQL Pharma
EQL Pharma is a pharmaceutical company focused on the development and commercialization of generic drugs. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations